MedCity News January 20, 2025
Here are three key trends that pharma leaders and clinical operations teams should monitor this year, along with a checklist of strategic priorities to stay ahead.
The pharmaceutical industry went through major changes in 2024, and there’s no sign of things slowing down in 2025. With innovation speeding up and patient needs constantly evolving, the industry faces the challenge of staying competitive and managing regulatory hurdles — all while finding ways to improve R&D and move diversity initiatives forward.
Here are three key trends that pharma leaders and clinical operations teams should monitor this year, along with a checklist of strategic priorities to stay ahead.
Trend #1: Embracing diversity from the start
Trial diversity isn’t yet mandatory in some regions,...
Today's Sponsors
Today's Sponsor